VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme

Molecular Medicine

Volumn 7, Issue 9, 2001, Pages 598-608

  Debinski, Waldemar ^a   Slagle Webb, Becky ^a   Achen, Marc G ^a   Stacker, Steven A ^a   Tulchinsky, Eugene ^a   Gillespie, G Yancey ^a   Gibo, Denise M ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; COMPLEMENTARY DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN C JUN; PROTEIN FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BRAIN TISSUE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DNA MICROARRAY; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL CULTURE; WESTERN BLOTTING; X CHROMOSOME;

EID: 0035718735     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401866     Document Type: Article

References (50)

1. Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors
2. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
3. Establishing a link between oncogenes and tumor angiogenesis
4. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family
5. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
6. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
7. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade glioma
8. Novel anti-brain tumor cytotoxins specific for cancer cells
9. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen
10. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation
11. New paths in human cancer serology
12. Cancer genetics/epigenetics and the X chromosome: Possible new links for malignant glioma pathogenesis and immune-based therapy
13. Mapping of the gene for vascular endothelial growth factor-D in mouse and man to the X chromosome
14. Monoclonal antibodies to vascular endothelial growth factor-D block its interaction with both VEGF receptor-2 and VEGF receptor-3
15. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
16. Human FIGF: Cloning, gene structure, and mapping to chromosome Xp22.1 between the PIGA and the GRPR genes
17. Insights about brain tumors gained through immunohistochemistry and in situ hybridization of nuclear and phenotypic markers
18. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers
19. Growth inhibition of newly established human glioma cell lines by leukemia inhibitory factor
20. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron
21. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells
22. Angiogenesis in cancer, vascular, rheumatoid and other diseases
23. Tumor angiogenesis: A quantitative method for histologic grading
24. Fos family members: Regulation, structure, and role in oncogenic transformation
25. Abnormal expression of OSM, CNTF and LIF in human brain tumors
26. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas
27. Oncostatin M stimulates c-Fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter
28. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B
29. Transformation by ras modifies AP1 composition and activity
30. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas
31. Placental vascularisation requires the AP-1 component Fra-1
32. A sequence-selective single-strand DNA-binding protein regulates basal transcription of the murine tissue inhibitor of metalloproteinases-1 (Timp-1) gene
33. Fra-2-positive auto-regulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK
34. Nuclear proto-oncogenes fos and jun
35. Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: Differential role of Fos proteins
36. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylationin in vitro by MAP kinase affects DNA binding activity
37. Fra-1 replaces c-Fos-dependent functions in mice
38. A peptide derived from the non-receptor binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin
39. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
40. Concentrations of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients
41. Flk-1 as a target for tumor growth inhibition
42. Halting angiogenesis suppresses carcinoma cell invasion
43. Anti-vascular endothelial growth factor receptor (Fetal Liver Kinase1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors
44. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption
45. Impact of oncogenes in tumor angiogenesis: Mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells
46. VEGF-D promotes the metastatic spread of tumor cells by the lymphatics
47. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo
48. High levels of c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model
49. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kB signal pathways